Mahler R J
West J Med. 1974 May;120(5):358-62.
Fifteen patients with maturity onset type diabetes, all of whom had received insulin for periods of one to thirty-five years, were admitted to hospital and insulin treatment was discontinued. Within 24 to 48 hours each patient was given an intravenous tolbutamide test, following which all were given either diet therapy alone or diet therapy plus oral agents. If significant hyperglycemia or ketonemia resulted, insulin therapy was reinstituted. Approximately 50 percent (8 of 15) of the patients showed improvement in fasting blood sugar levels following discontinuation of insulin. It was not possible to distinguish the insulin independent from the insulin dependent group using such criteria as age, sex, degree of overweight, insulin dosage, duration of diabetes or duration of insulin therapy. However, using the intravenous tolbutamide test it was possible to differentiate between the two groups. Those who did not require insulin responded to intravenous tolbutamide with a glucose decrease greater than 10 percent from the initial value. The insulin dependent group had either no glucose decrease or a rise in blood glucose following intravenous administration of tolbutamide.
15例成年起病型糖尿病患者,均接受胰岛素治疗1至35年,入院后停用胰岛素治疗。在24至48小时内,对每位患者进行静脉注射甲苯磺丁脲试验,之后所有患者均接受单纯饮食治疗或饮食治疗加口服降糖药。如果出现明显高血糖或酮血症,则重新开始胰岛素治疗。约50%(15例中的8例)患者在停用胰岛素后空腹血糖水平有所改善。使用年龄、性别、超重程度、胰岛素剂量、糖尿病病程或胰岛素治疗时间等标准,无法区分胰岛素非依赖组和胰岛素依赖组。然而,通过静脉注射甲苯磺丁脲试验,可以区分这两组。不需要胰岛素的患者静脉注射甲苯磺丁脲后血糖下降幅度超过初始值的10%。胰岛素依赖组静脉注射甲苯磺丁脲后血糖无下降或血糖升高。